| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.6M | -12.4% |
| Cost of Revenue | $619K | +275.4% |
| R&D Expense | $49.1M | +405.4% |
| SG&A Expense | $130.6M | +1371.1% |
| Operating Income | -$186.0M | -459.1% |
| Interest Expense | $3.1M | -92.2% |
| Pre-tax Income | -$400.9M | -2085.5% |
| Income Tax | $0 | -100.0% |
| Net Income | -$400.9M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $170.2M | — |
| Short-term Investments | $606.5M | — |
| Accounts Receivable | $17K | -78.5% |
| Current Assets | $784.3M | — |
| Total Assets | $938.3M | +201.7% |
| Current Liabilities | $17.3M | -69.2% |
| Total Liabilities | $24.7M | -62.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$61.0M | -1087.5% |
| Capital Expenditures | $5.0M | — |
| Investing Cash Flow | -$618.6M | — |
| Financing Cash Flow | $847.2M | — |
| Free Cash Flow | -$66.0M | -1184.9% |
| -1731.2% |
| EPS (Basic) | -$2.36 | -252.2% |
| EPS (Diluted) | -$2.36 | -252.2% |
| Stockholders' Equity |
| $913.6M |
| +1530.5% |